Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Running on Fish Oil: Benefits of Omega-3 Supplementation and Exercise
Allison Hill reported new research findings on adjunct supplementation with fish oil in obese or overweight subjects (25 – 65 years old) assigned to a regular exercise regimen. Body compositions as increased by Dual Energy X-ray Absorptiometry revealed that the only group to exhibit a significant reduction in % body fat was that combining exercise with fish oil supplementation. This improvement appeared to reflect an enhanced fat oxidation during exercise.
- Running on Fish Oil: Benefits of Omega-3 Supplementation and Exercise
Allison Hill reported new research findings on adjunct supplementation with fish oil in obese or overweight subjects (25 – 65 years old) assigned to a regular exercise regimen. Body compositions as increased by Dual Energy X-ray Absorptiometry revealed that the only group to exhibit a significant reduction in % body fat was that combining exercise with fish oil supplementation. This improvement appeared to reflect an enhanced fat oxidation during exercise.
- Anti-inflammatory Effects of Omega-3 Fatty Acid Supplementation on Atherosclerotic Plaques in Patients
A recent clinical trial wherein supplementary fish oil
containing omega-3 fatty acids was given to patients for a median time of
3 weeks (up to 7 weeks) prior to surgical removal of their advanced
carotid atherosclerotic plaques
- Anti-inflammatory Effects of Omega-3 Fatty Acid Supplementation on Atherosclerotic Plaques in Patients
A recent clinical trial wherein supplementary fish oil
containing omega-3 fatty acids was given to patients for a median time of
3 weeks (up to 7 weeks) prior to surgical removal of their advanced
carotid atherosclerotic plaques
- Anti-inflammatory Effects of Omega-3 Fatty Acid Supplementation on Atherosclerotic Plaques in Patients
A recent clinical trial wherein supplementary fish oil
containing omega-3 fatty acids was given to patients for a median time of
3 weeks (up to 7 weeks) prior to surgical removal of their advanced
carotid atherosclerotic plaques
- Anti-inflammatory Effects of Omega-3 Fatty Acid Supplementation on Atherosclerotic Plaques in Patients
A recent clinical trial wherein supplementary fish oil
containing omega-3 fatty acids was given to patients for a median time of
3 weeks (up to 7 weeks) prior to surgical removal of their advanced
carotid atherosclerotic plaques
- Anti-inflammatory Effects of Omega-3 Fatty Acid Supplementation on Atherosclerotic Plaques in Patients
A recent clinical trial wherein supplementary fish oil
containing omega-3 fatty acids was given to patients for a median time of
3 weeks (up to 7 weeks) prior to surgical removal of their advanced
carotid atherosclerotic plaques
- Anti-inflammatory Effects of Omega-3 Fatty Acid Supplementation on Atherosclerotic Plaques in Patients
A recent clinical trial wherein supplementary fish oil
containing omega-3 fatty acids was given to patients for a median time of
3 weeks (up to 7 weeks) prior to surgical removal of their advanced
carotid atherosclerotic plaques
- Anti-inflammatory Effects of Omega-3 Fatty Acid Supplementation on Atherosclerotic Plaques in Patients
A recent clinical trial wherein supplementary fish oil
containing omega-3 fatty acids was given to patients for a median time of
3 weeks (up to 7 weeks) prior to surgical removal of their advanced
carotid atherosclerotic plaques
- Anti-inflammatory Effects of Omega-3 Fatty Acid Supplementation on Atherosclerotic Plaques in Patients
A recent clinical trial wherein supplementary fish oil
containing omega-3 fatty acids was given to patients for a median time of
3 weeks (up to 7 weeks) prior to surgical removal of their advanced
carotid atherosclerotic plaques
- Mannatech Introduces a Revolutionary Advancement in Vitamin, Mineral and Phytochemical Supplementation
Mannatech, Incorporated announces it plans to introduce PhytoMatrix, a supplement containing fully standardized and completely plant-based vitamins, minerals and phytochemicals.
- Formation of ASEAN Alliance of Health Supplement Associations (AAHSA) Announced
A new regional grouping of the dietary & health supplement industry has been created this week in Singapore. The ASEAN Alliance of Health Supplement Associations (AAHSA) brings together the supplement industry associations in Indonesia, Malaysia, Philippines, Singapore, Thailand and Vietnam.
- Formation of ASEAN Alliance of Health Supplement Associations (AAHSA) Announced
A new regional grouping of the dietary & health supplement industry has been created this week in Singapore. The ASEAN Alliance of Health Supplement Associations (AAHSA) brings together the supplement industry associations in Indonesia, Malaysia, Philippines, Singapore, Thailand and Vietnam.
- Formation of ASEAN Alliance of Health Supplement Associations (AAHSA) Announced
A new regional grouping of the dietary & health supplement industry has been created this week in Singapore. The ASEAN Alliance of Health Supplement Associations (AAHSA) brings together the supplement industry associations in Indonesia, Malaysia, Philippines, Singapore, Thailand and Vietnam.
- Fish Oil Provides 24-Hour Control of Circulating Fat Levels
The research study, reported in Cairns, Australia by Professor Bruce Holub at the Congress for the International Society for the study of Fatty Acids and Lipids, evaluated the effect of supplementation with DHA/EPA omega-3 fatty acids from fish oil on blood triglyceride levels throughout the 24-hour period. Findings indicate that DHA/EPA omega-3 fatty acid supplementation, taken daily in the morning or evening on a regular basis, can provide 24-hour risk reduction of blood triglyceride levels before, between, and after meals.
- Fish Oil Provides 24-Hour Control of Circulating Fat Levels
The research study, reported in Cairns, Australia by Professor Bruce Holub at the Congress for the International Society for the study of Fatty Acids and Lipids, evaluated the effect of supplementation with DHA/EPA omega-3 fatty acids from fish oil on blood triglyceride levels throughout the 24-hour period. Findings indicate that DHA/EPA omega-3 fatty acid supplementation, taken daily in the morning or evening on a regular basis, can provide 24-hour risk reduction of blood triglyceride levels before, between, and after meals.
- Fish Oil Provides 24-Hour Control of Circulating Fat Levels
The research study, reported in Cairns, Australia by Professor Bruce Holub at the Congress for the International Society for the study of Fatty Acids and Lipids, evaluated the effect of supplementation with DHA/EPA omega-3 fatty acids from fish oil on blood triglyceride levels throughout the 24-hour period. Findings indicate that DHA/EPA omega-3 fatty acid supplementation, taken daily in the morning or evening on a regular basis, can provide 24-hour risk reduction of blood triglyceride levels before, between, and after meals.
- Fish Oil Provides 24-Hour Control of Circulating Fat Levels
The research study, reported in Cairns, Australia by Professor Bruce Holub at the Congress for the International Society for the study of Fatty Acids and Lipids, evaluated the effect of supplementation with DHA/EPA omega-3 fatty acids from fish oil on blood triglyceride levels throughout the 24-hour period. Findings indicate that DHA/EPA omega-3 fatty acid supplementation, taken daily in the morning or evening on a regular basis, can provide 24-hour risk reduction of blood triglyceride levels before, between, and after meals.
- Fish Oil Provides 24-Hour Control of Circulating Fat Levels
The research study, reported in Cairns, Australia by Professor Bruce Holub at the Congress for the International Society for the study of Fatty Acids and Lipids, evaluated the effect of supplementation with DHA/EPA omega-3 fatty acids from fish oil on blood triglyceride levels throughout the 24-hour period. Findings indicate that DHA/EPA omega-3 fatty acid supplementation, taken daily in the morning or evening on a regular basis, can provide 24-hour risk reduction of blood triglyceride levels before, between, and after meals.
- Fish Oil Provides 24-Hour Control of Circulating Fat Levels
The research study, reported in Cairns, Australia by Professor Bruce Holub at the Congress for the International Society for the study of Fatty Acids and Lipids, evaluated the effect of supplementation with DHA/EPA omega-3 fatty acids from fish oil on blood triglyceride levels throughout the 24-hour period. Findings indicate that DHA/EPA omega-3 fatty acid supplementation, taken daily in the morning or evening on a regular basis, can provide 24-hour risk reduction of blood triglyceride levels before, between, and after meals.
- Herbal Medicine Symposium Offered at Penn
The University of Pennsylvania’s School of Medicine, School of Nursing and Morris Arboretum are jointly sponsoring a symposium on September 19-20, 2006 entitled Herbal Medicine: Perception, Practice and Rational Use. The symposium will focus on: the use of plants in clinical practice; determining benefits or harm; rational approaches for proper use; informing the public; perceptions of herbal medicine by healthcare providers and the public; and botanical research.
- Herbal Medicine Symposium Offered at Penn
The University of Pennsylvania’s School of Medicine, School of Nursing and Morris Arboretum are jointly sponsoring a symposium on September 19-20, 2006 entitled Herbal Medicine: Perception, Practice and Rational Use. The symposium will focus on: the use of plants in clinical practice; determining benefits or harm; rational approaches for proper use; informing the public; perceptions of herbal medicine by healthcare providers and the public; and botanical research.
- Herbal Medicine Symposium Offered at Penn
The University of Pennsylvania’s School of Medicine, School of Nursing and Morris Arboretum are jointly sponsoring a symposium on September 19-20, 2006 entitled Herbal Medicine: Perception, Practice and Rational Use. The symposium will focus on: the use of plants in clinical practice; determining benefits or harm; rational approaches for proper use; informing the public; perceptions of herbal medicine by healthcare providers and the public; and botanical research.
- Herbal Medicine Symposium Offered at Penn
The University of Pennsylvania’s School of Medicine, School of Nursing and Morris Arboretum are jointly sponsoring a symposium on September 19-20, 2006 entitled Herbal Medicine: Perception, Practice and Rational Use. The symposium will focus on: the use of plants in clinical practice; determining benefits or harm; rational approaches for proper use; informing the public; perceptions of herbal medicine by healthcare providers and the public; and botanical research.
- Herbal Medicine Symposium Offered at Penn
The University of Pennsylvania’s School of Medicine, School of Nursing and Morris Arboretum are jointly sponsoring a symposium on September 19-20, 2006 entitled Herbal Medicine: Perception, Practice and Rational Use. The symposium will focus on: the use of plants in clinical practice; determining benefits or harm; rational approaches for proper use; informing the public; perceptions of herbal medicine by healthcare providers and the public; and botanical research.
- Repeat Offenders Banned From Claiming Products Treat or Cure Diseases
The FTC alleged the sellers of Dia-Cope, a pill claimed to prevent, treat, and cure diabetes violated a previous court order by misrepresenting the health benefits of their product and misrepresenting that clinical trials proved their claims and is banned from claiming its products treat or cure diseases and the defendants will give up all of the assets they received from the sale of the product.
- Repeat Offenders Banned From Claiming Products Treat or Cure Diseases
The FTC alleged the sellers of Dia-Cope, a pill claimed to prevent, treat, and cure diabetes violated a previous court order by misrepresenting the health benefits of their product and misrepresenting that clinical trials proved their claims and is banned from claiming its products treat or cure diseases and the defendants will give up all of the assets they received from the sale of the product.
- Repeat Offenders Banned From Claiming Products Treat or Cure Diseases
The FTC alleged the sellers of Dia-Cope, a pill claimed to prevent, treat, and cure diabetes violated a previous court order by misrepresenting the health benefits of their product and misrepresenting that clinical trials proved their claims and is banned from claiming its products treat or cure diseases and the defendants will give up all of the assets they received from the sale of the product.
- NBTY to Acquire Ester-C(R)
Company has entered into a contract to acquire Zila Nutraceuticals, Inc., manufacturer and marketer of the Ester-C(R) nutritional supplement brand, for approximately $40 million in cash, including up to a $3 million contingent payment which is based upon EBITDA performance. Zila Nutraceuticals Inc. is a business unit of Zila, Inc. (Nasdaq: ZILA).
- NBTY to Acquire Ester-C(R)
Company has entered into a contract to acquire Zila Nutraceuticals, Inc., manufacturer and marketer of the Ester-C(R) nutritional supplement brand, for approximately $40 million in cash, including up to a $3 million contingent payment which is based upon EBITDA performance. Zila Nutraceuticals Inc. is a business unit of Zila, Inc. (Nasdaq: ZILA).
- NBTY to Acquire Ester-C(R)
Company has entered into a contract to acquire Zila Nutraceuticals, Inc., manufacturer and marketer of the Ester-C(R) nutritional supplement brand, for approximately $40 million in cash, including up to a $3 million contingent payment which is based upon EBITDA performance. Zila Nutraceuticals Inc. is a business unit of Zila, Inc. (Nasdaq: ZILA).
- Vanderbilt-Ingram Cancer Center researchers find ginseng may improve breast cancer outcomes
Study by Vanderbilt-Ingram Cancer Center researchers, published online recently in the American Journal of Epidemiology, indicates that ginseng may improve survival and quality of life after a diagnosis of breast cancer
- Vanderbilt-Ingram Cancer Center researchers find ginseng may improve breast cancer outcomes
Study by Vanderbilt-Ingram Cancer Center researchers, published online recently in the American Journal of Epidemiology, indicates that ginseng may improve survival and quality of life after a diagnosis of breast cancer
- Vanderbilt-Ingram Cancer Center researchers find ginseng may improve breast cancer outcomes
Study by Vanderbilt-Ingram Cancer Center researchers, published online recently in the American Journal of Epidemiology, indicates that ginseng may improve survival and quality of life after a diagnosis of breast cancer
- Vanderbilt-Ingram Cancer Center researchers find ginseng may improve breast cancer outcomes
Study by Vanderbilt-Ingram Cancer Center researchers, published online recently in the American Journal of Epidemiology, indicates that ginseng may improve survival and quality of life after a diagnosis of breast cancer
- Cardinal Nutrition Hires Tim Gardner as Vice President of Operations
Company announces that it has hired Tim Gardner as its new vice president of operations, to be responsible for plant operations including manufacturing and distribution of products, facilities safety and regulatory compliance.
- Cardinal Nutrition Hires Tim Gardner as Vice President of Operations
Company announces that it has hired Tim Gardner as its new vice president of operations, to be responsible for plant operations including manufacturing and distribution of products, facilities safety and regulatory compliance.
- Cardinal Nutrition Hires Tim Gardner as Vice President of Operations
Company announces that it has hired Tim Gardner as its new vice president of operations, to be responsible for plant operations including manufacturing and distribution of products, facilities safety and regulatory compliance.
- Cardinal Nutrition Hires Tim Gardner as Vice President of Operations
Company announces that it has hired Tim Gardner as its new vice president of operations, to be responsible for plant operations including manufacturing and distribution of products, facilities safety and regulatory compliance.
- Cardinal Nutrition Hires Tim Gardner as Vice President of Operations
Company announces that it has hired Tim Gardner as its new vice president of operations, to be responsible for plant operations including manufacturing and distribution of products, facilities safety and regulatory compliance.
- Contract Manufacturer Health Wright Products announces completion of major expansion and relocation
has relocated to its new state of the art 120,350 square foot facility.
- Contract Manufacturer Health Wright Products announces completion of major expansion and relocation
has relocated to its new state of the art 120,350 square foot facility.
- Contract Manufacturer Health Wright Products announces completion of major expansion and relocation
has relocated to its new state of the art 120,350 square foot facility.
- Appeals Court Rules for FDA in Ephedra Ban: Overturns Lower Court Finding in Nutraceutical v. von Eschenbach
A three-judge panel of the 10th Circuit U.S. Court of Appeals ruled yesterday in favor of the U.S. Food and Drug Administration (FDA) in a case that had challenged the agency's 2004 prohibition of any level of ephedrine in dietary supplements. "The evidence in the administrative record was sufficiently probative to demonstrate by a preponderance of the evidence that EDS [ephedrine dietary supplements] at any dose level pose an unreasonable risk. The greater weight of the evidence supports the FDA’s ban on EDS, thus satisfying the agency's burden."
- Appeals Court Rules for FDA in Ephedra Ban: Overturns Lower Court Finding in Nutraceutical v. von Eschenbach
A three-judge panel of the 10th Circuit U.S. Court of Appeals ruled yesterday in favor of the U.S. Food and Drug Administration (FDA) in a case that had challenged the agency's 2004 prohibition of any level of ephedrine in dietary supplements. "The evidence in the administrative record was sufficiently probative to demonstrate by a preponderance of the evidence that EDS [ephedrine dietary supplements] at any dose level pose an unreasonable risk. The greater weight of the evidence supports the FDA’s ban on EDS, thus satisfying the agency's burden."
- Appeals Court Rules for FDA in Ephedra Ban: Overturns Lower Court Finding in Nutraceutical v. von Eschenbach
A three-judge panel of the 10th Circuit U.S. Court of Appeals ruled yesterday in favor of the U.S. Food and Drug Administration (FDA) in a case that had challenged the agency's 2004 prohibition of any level of ephedrine in dietary supplements. "The evidence in the administrative record was sufficiently probative to demonstrate by a preponderance of the evidence that EDS [ephedrine dietary supplements] at any dose level pose an unreasonable risk. The greater weight of the evidence supports the FDA’s ban on EDS, thus satisfying the agency's burden."
- FDA Statement on Tenth Circuit’s Ruling to Uphold FDA Decision Banning Dietary Supplements Containing Ephedrine Alkaloids
FDA states that no dosage of dietary supplements containing ephedrine alkaloids is safe and the sale of these products in the United States is illegal and subject to FDA enforcement action.
- FDA Statement on Tenth Circuit’s Ruling to Uphold FDA Decision Banning Dietary Supplements Containing Ephedrine Alkaloids
FDA states that no dosage of dietary supplements containing ephedrine alkaloids is safe and the sale of these products in the United States is illegal and subject to FDA enforcement action.
- FDA Statement on Tenth Circuit’s Ruling to Uphold FDA Decision Banning Dietary Supplements Containing Ephedrine Alkaloids
FDA states that no dosage of dietary supplements containing ephedrine alkaloids is safe and the sale of these products in the United States is illegal and subject to FDA enforcement action.
- FDA Statement on Tenth Circuit’s Ruling to Uphold FDA Decision Banning Dietary Supplements Containing Ephedrine Alkaloids
FDA states that no dosage of dietary supplements containing ephedrine alkaloids is safe and the sale of these products in the United States is illegal and subject to FDA enforcement action.
- USANA Health Sciences Teams up with Premiere Athletes of Sony Ericsson WTA Tour
USANA Health Sciences Inc. and the Sony Ericsson WTA Tour have signed an agreement that will provide Tour players with vitamins and health supplements that are backed by an athlete guarantee of purity from any substances prohibited by the World Anti-Doping Agency (WADA). Under the terms of the agreement, should any Sony Ericsson WTA Tour athlete test positive for a substance prohibited by WADA due to her use of USANA products, USANA will pay the player twice her prize money earnings from the prior year, up to $1 million.
- USANA Health Sciences Teams up with Premiere Athletes of Sony Ericsson WTA Tour
USANA Health Sciences Inc. and the Sony Ericsson WTA Tour have signed an agreement that will provide Tour players with vitamins and health supplements that are backed by an athlete guarantee of purity from any substances prohibited by the World Anti-Doping Agency (WADA). Under the terms of the agreement, should any Sony Ericsson WTA Tour athlete test positive for a substance prohibited by WADA due to her use of USANA products, USANA will pay the player twice her prize money earnings from the prior year, up to $1 million.
- USANA Health Sciences Teams up with Premiere Athletes of Sony Ericsson WTA Tour
USANA Health Sciences Inc. and the Sony Ericsson WTA Tour have signed an agreement that will provide Tour players with vitamins and health supplements that are backed by an athlete guarantee of purity from any substances prohibited by the World Anti-Doping Agency (WADA). Under the terms of the agreement, should any Sony Ericsson WTA Tour athlete test positive for a substance prohibited by WADA due to her use of USANA products, USANA will pay the player twice her prize money earnings from the prior year, up to $1 million.
- Consumer Protection Deputy Director To Leave FTC
C. Lee Peeler, deputy director of the Bureau of Consumer Protection for the past five years, will leave the FTC, to become president of the National Advertising Review Council and Executive Vice President for National Advertising and Self-Regulation of the Council of Better Business Bureaus.
- Consumer Protection Deputy Director To Leave FTC
C. Lee Peeler, deputy director of the Bureau of Consumer Protection for the past five years, will leave the FTC, to become president of the National Advertising Review Council and Executive Vice President for National Advertising and Self-Regulation of the Council of Better Business Bureaus.
- Consumer Protection Deputy Director To Leave FTC
C. Lee Peeler, deputy director of the Bureau of Consumer Protection for the past five years, will leave the FTC, to become president of the National Advertising Review Council and Executive Vice President for National Advertising and Self-Regulation of the Council of Better Business Bureaus.
- Consumer Protection Deputy Director To Leave FTC
C. Lee Peeler, deputy director of the Bureau of Consumer Protection for the past five years, will leave the FTC, to become president of the National Advertising Review Council and Executive Vice President for National Advertising and Self-Regulation of the Council of Better Business Bureaus.
- Consumer Protection Deputy Director To Leave FTC
C. Lee Peeler, deputy director of the Bureau of Consumer Protection for the past five years, will leave the FTC, to become president of the National Advertising Review Council and Executive Vice President for National Advertising and Self-Regulation of the Council of Better Business Bureaus.
- Healthy Foods Conference October 4-5, 2006
The 3rd annual Healthy Foods Conference, October 4-5, 2006, will be held at the Sheraton Inner Harbor Hotel, Baltimore, Maryland to discuss the future of healthy foods and how industry leaders are responding.
- Healthy Foods Conference October 4-5, 2006
The 3rd annual Healthy Foods Conference, October 4-5, 2006, will be held at the Sheraton Inner Harbor Hotel, Baltimore, Maryland to discuss the future of healthy foods and how industry leaders are responding.
- Healthy Foods Conference October 4-5, 2006
The 3rd annual Healthy Foods Conference, October 4-5, 2006, will be held at the Sheraton Inner Harbor Hotel, Baltimore, Maryland to discuss the future of healthy foods and how industry leaders are responding.
- Healthy Foods Conference October 4-5, 2006
The 3rd annual Healthy Foods Conference, October 4-5, 2006, will be held at the Sheraton Inner Harbor Hotel, Baltimore, Maryland to discuss the future of healthy foods and how industry leaders are responding.
- Healthy Foods Conference October 4-5, 2006
The 3rd annual Healthy Foods Conference, October 4-5, 2006, will be held at the Sheraton Inner Harbor Hotel, Baltimore, Maryland to discuss the future of healthy foods and how industry leaders are responding.
- FDA Asks U.S. Marshals to Seize Dietary Supplements Products Being Promoted With Drug Claims
At the request of the U.S. Food and Drug Administration (FDA), on September 5, 2006, U.S. Marshals seized quantities of Ellagimax capsules, Coral Max capsules, Coral Max without Iron capsules, and Advanced Arthritis Support capsules distributed by Advantage Nutraceuticals L.L.C. of Fort Walton Beach, Florida, valued at approximately $55,000.00. The products are alleged to be in violation of the new drug and misbranding provisions of the Federal Food, Drug and Cosmetic Act.
- FDA Asks U.S. Marshals to Seize Dietary Supplements Products Being Promoted With Drug Claims
At the request of the U.S. Food and Drug Administration (FDA), on September 5, 2006, U.S. Marshals seized quantities of Ellagimax capsules, Coral Max capsules, Coral Max without Iron capsules, and Advanced Arthritis Support capsules distributed by Advantage Nutraceuticals L.L.C. of Fort Walton Beach, Florida, valued at approximately $55,000.00. The products are alleged to be in violation of the new drug and misbranding provisions of the Federal Food, Drug and Cosmetic Act.
- FDA Asks U.S. Marshals to Seize Dietary Supplements Products Being Promoted With Drug Claims
At the request of the U.S. Food and Drug Administration (FDA), on September 5, 2006, U.S. Marshals seized quantities of Ellagimax capsules, Coral Max capsules, Coral Max without Iron capsules, and Advanced Arthritis Support capsules distributed by Advantage Nutraceuticals L.L.C. of Fort Walton Beach, Florida, valued at approximately $55,000.00. The products are alleged to be in violation of the new drug and misbranding provisions of the Federal Food, Drug and Cosmetic Act.
- FDA Asks U.S. Marshals to Seize Dietary Supplements Products Being Promoted With Drug Claims
At the request of the U.S. Food and Drug Administration (FDA), on September 5, 2006, U.S. Marshals seized quantities of Ellagimax capsules, Coral Max capsules, Coral Max without Iron capsules, and Advanced Arthritis Support capsules distributed by Advantage Nutraceuticals L.L.C. of Fort Walton Beach, Florida, valued at approximately $55,000.00. The products are alleged to be in violation of the new drug and misbranding provisions of the Federal Food, Drug and Cosmetic Act.
- FDA Asks U.S. Marshals to Seize Dietary Supplements Products Being Promoted With Drug Claims
At the request of the U.S. Food and Drug Administration (FDA), on September 5, 2006, U.S. Marshals seized quantities of Ellagimax capsules, Coral Max capsules, Coral Max without Iron capsules, and Advanced Arthritis Support capsules distributed by Advantage Nutraceuticals L.L.C. of Fort Walton Beach, Florida, valued at approximately $55,000.00. The products are alleged to be in violation of the new drug and misbranding provisions of the Federal Food, Drug and Cosmetic Act.
- EuroPharma Signs Exclusive Agreement With New Chapter to Distribute Vectomega® Into Health Food/Natural Product Retail Channel
EuroPharma and New Chapter have signed an agreement appointing New Chapter as the exclusive distributor of Vectomega® for the health food/natural product retail channel.
- EuroPharma Signs Exclusive Agreement With New Chapter to Distribute Vectomega® Into Health Food/Natural Product Retail Channel
EuroPharma and New Chapter have signed an agreement appointing New Chapter as the exclusive distributor of Vectomega® for the health food/natural product retail channel.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
BALTIMORE, MD (August 16, 2006) – The 12th Annual Socially Responsible Business Awards (SRBA) will be presented at a free breakfast event open to all Natural Products Expo East attendees on Friday, October 6, 2006, from 8:00 – 9:30 am at the Baltimore Convention Center, Baltimore, MD. The keynote speaker will be long-time SRBA supporter Michael Funk, who has resumed his role as CEO of leading natural foods distributor United Natural Foods (UNFI). Mr. Funk will speak about the state of our industry and the issues it faces moving forward,
This annual event, held in conjunction with Natural Products Expo East and open to all members of the natural products industry, honors the highest human ideals applied to business practices. SRBA recipients demonstrate exceptional track records in ethics, accountability, governance, employment practices, business relationships, financial return, products and services, community involvement and environmental protection. The keynote speaker is always a business leader at the forefront of the socially responsible business movement, and this year’s speaker is no exception.
Michael Funk founded Mountain People’s Warehouse, a natural products distributor, in 1976. As one of the pioneers of the natural products industry, he built that company into a leading regional natural foods wholesaler while maintaining the values upon which the company was founded. In early 1996, Funk and Norman Cloutier, founder of east-coast based natural foods distributor Cornucopia, joined their organizations together to form United Natural Foods, the largest national natural-foods distributor in the US. They took the company public in November of that year.
The event will also feature a live musical performance by Spirit Voyage recording artist Snatam Kaur.
Golden Temple Bakery, the manufacturer of Peace Cereals; Sunshine Spa and Soothing Touch Health and Beauty Products; and the Yogi Tea Company sponsor the annual breakfast event. Co-sponsors of the 2006 SRBA event to date include NOW Foods Dr. Bronners, White Wave, Guayaki, New Hope Natural Media, John Beske Communications, The Shelton Group PR and Dagoba Organic Chocolates.
Sponsorship opportunities for the 2006 event are still available. For more information, please contact Jill Ettinger, jillettinger@mindspring.com
-END-
CONTACT:
Suzanne Shelton, The Shelton Group
Suzanne@SheltonGroupPR.com
847.676.4337 |